Clinical trialPhase 3
ACCLAIM-Lp(a)
NCT06292013
~17 300 participants; outcome readout ориентировочно 2029.
Also in the catalogue
- Lp(a)HORIZON (pelacarsen)Clinical trial
- OCEAN(a)-OutcomesClinical trial
- PelacarsenDrug
- ACCLAIM-CTAClinical trial
- CORALreef OutcomesClinical trial
- STX-1150 (Tune/CasX epigenetic PCSK9 silencing), first-in-humanClinical trial
Scales
Identifiers
- NCT
- NCT06292013
Original sources
Details
- Phase
- Phase 3
- Status
- Active, not recruiting
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.